News

Published on 5 Nov 2024 on Benzinga

S&P 500 Gains 1%; Vimeo Shares Spike Higher - Vimeo (NASDAQ:VMEO)


Article preview image

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 points on Tuesday.

The Dow traded up 0.86% to 42,154.69 while the NASDAQ rose 1.25% to 18,407.20. The S&P 500 also rose, gaining, 1.01% to 5,770.63.

NASDAQ.BVS price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
BVS Stock Gains Post Divestiture of Advanced Rehabilitation Business

Bioventus Inc. BVS announced the completion of its earlier-announced divestiture of the Advanced...

Zacks · via Yahoo Finance 3 Jan 2025

Is Bioventus (BVS) Outperforming Other Medical Stocks This Year?

The Medical group has plenty of great stocks, but investors should always be looking for companie...

Zacks · via Yahoo Finance 23 Dec 2024

Encore Wire Corp Exits Highlight Chuck Royce's Latest Investment Moves

The stock traded at an average price of $8.83 during the quarter. First Bancshares Inc (NYSE:FBMS...

GuruFocus.com · via Yahoo Finance 6 Nov 2024

Earnings call: Bioventus reports robust Q3 growth, raises full-year guidance By...

During the third quarter of 2024, Bioventus , a global leader in orthobiologic solutions, reporte...

Investing.com 6 Nov 2024

S&P 500 Gains 1%; Vimeo Shares Spike Higher - Vimeo (NASDAQ:VMEO)

U.S. stocks traded higher midway through trading, with the Dow Jones index gaining more than 350 ...

Benzinga 5 Nov 2024

Tesla, Celanese among Tuesday's morning market cap stock movers By Investing.com

Tesla, Celanese among Tuesday's morning market cap stock movers

Investing.com 5 Nov 2024

Bioventus Inc (BVS) Q3 2024 Earnings Report Preview: What To Look For

Bioventus Inc (NASDAQ:BVS) is set to release its Q3 2024 earnings on Nov 5, 2024. The consensus...

GuruFocus.com · via Yahoo Finance 5 Nov 2024

Biogen (BIIB) Gets EU Approval for Rare Disease Drug Qalsody

Biogen BIIB announced that the European Commission (EC) has granted marketing approval to Qalsody...

Zacks via Yahoo Finance 31 May 2024

Here's Why You Should Buy Acrivon Therapeutics (ACRV) Stock

Acrivon Therapeutics ACRV is a precision oncology company that has seen significant progress acro...

Zacks via Yahoo Finance 28 May 2024

Here's Why You Should Retain Centene (CNC) Stock for Now

Centene Corporation CNC is currently aided by improved premium and service revenues, Medicaid...

Zacks · via Yahoo Finance 21 May 2024